Innovative solution for epilepsy diagnosis and monitoring
INVESTING IN THE FUTURE OF HEALTHCARE
Idinvest Partners, a major player in the financing of European SMEs, helps innovative health-sector companies grow through our exclusive, long-term partnership with Kurma Partners, a European specialist in financing healthcare and biotech firms. Kurma Partners and Idinvest Partners’ health-sector investments focus on innovative solutions with high-impact medical applications. Kurma has recently developed a digital diagnostics franchise and built up a portfolio of companies offering disruptive technologies.
Our support for innovative health-sector companies has totaled more than €156 million over the past 10 years, invested in more than 50 companies in Europe, 17 of which have been listed on the stock exchange.
OUR INVESTMENT STRATEGY SETS THE BAR HIGH
Kurma Partners and Idinvest Partners select companies that meet our stringent requirements for both performance and innovation. Priority investment targets are digital diagnostics and therapeutics in areas where medical needs are largely unmet, with swift paths to profitability (four to five years) following the first clinical proof of concept. These include rare diseases, neuroscience, oncology and immunology.
Alongside Kurma Partners, we have helped launch more than 10 biotech companies, obtaining new clinical data to license new treatments, developing and marketing six new treatments for serious diseases, and developing new screening techniques for cancer and certain neurodegenerative diseases.
The word of the investor
The pharmaceutical industry is seeing a divergence between innovators and marketers, and our business clearly fits within this trend. We capture value by working closely with academic research labs and optimizing technologies now widely used by industry players. We are very confident about the opportunities taking shape in Europe in both biotech and the emerging regulated e-health sector.
REMI DROLLER, THIERRY LAUGEL AND VANESSA MALIER, MANAGING PARTNERS AT KURMA PARTNERS